Best Over-the-Counter Weight Loss Medications: What Actually Works

Orlistat — sold over the counter as Alli — is the only FDA-approved over-the-counter weight loss medication available in the United States [1]. It blocks roughly 25% of the fat you eat from being absorbed, which adds modest extra weight loss on top of diet and exercise [1][2]. Everything else on the OTC shelf is a dietary supplement, not an FDA-reviewed drug, and most have weak or inconsistent evidence behind them [3]. For meaningful weight loss, prescription options like GLP-1 medications are typically far more effective in published trials [4][5]. Individual results vary.

What over-the-counter weight loss medications are available?

When patients ask about OTC weight loss meds, they're usually mixing two very different categories: FDA-approved drugs sold without a prescription, and dietary supplements. The distinction matters because it changes what the FDA has actually checked before a product reaches the shelf.

FDA-approved OTC: orlistat (Alli)

Orlistat 60mg (brand name Alli) is the only weight loss drug the FDA has approved for over-the-counter sale, a decision finalized in 2007 [1]. It's a lower-strength version of prescription orlistat (Xenical, 120mg). The Alli label describes use in adults aged 18 and older with a BMI of 25 or higher, together with a reduced-calorie, low-fat diet [1]. Common side effects include oily stools, gas with discharge, and urgent bowel movements; orlistat is contraindicated in pregnancy, chronic malabsorption syndromes, and cholestasis [1].

OTC supplements (not FDA-approved as drugs)

Walk down any pharmacy aisle and you'll find "fat burners," "metabolism boosters," and "Ozempic alternatives." These are dietary supplements regulated under the 1994 Dietary Supplement Health and Education Act (DSHEA). The FDA does not review them for safety or effectiveness as drugs before they are sold [3]. The manufacturer is responsible for safety claims, and the FDA can generally act only after a problem appears on the market [3][9].

How does orlistat (Alli) work and how well does it work?

Mechanism: blocking dietary fat absorption

Orlistat is a lipase inhibitor. It binds to the digestive enzymes (lipases) in your gut that would normally break down dietary fat, so about 25% of the fat you eat passes through undigested and is eliminated in stool [1][2]. Unlike GLP-1 medications, orlistat doesn't act on appetite or the brain — it works entirely in the gut, on the fat eaten at that meal.

Expected weight loss and clinical evidence

In randomized trials, adults taking the OTC orlistat regimen studied in published research with a reduced-calorie diet lost an average of about 5–6% of body weight over one year, compared with roughly 3% on diet plus placebo [2]. That works out to a few extra pounds for most people. The prescription strength studied in trials produced slightly more — around 8–10% — but with more GI side effects [2]. Individual results vary, and orlistat does not work without dietary changes.

Common side effects and contraindications

Because orlistat works by passing fat through the gut, side effects are mostly digestive: oily or fatty stools, gas with discharge, urgent bowel movements, and stomach pain [1][2]. These are more likely after high-fat meals. Rare but serious risks reported on the FDA label include liver injury and reduced absorption of fat-soluble vitamins A, D, E, and K; the label suggests a daily multivitamin taken at bedtime [1]. Orlistat is contraindicated in pregnancy, in people with chronic malabsorption syndromes, and in those with cholestasis [1]. Patients taking warfarin, cyclosporine, levothyroxine, or certain seizure medications should speak with a clinician or pharmacist before use because orlistat can change how those medications are absorbed [1].

What about OTC supplements that claim to mimic Ozempic?

"Nature's Ozempic" is a marketing phrase, not a medical category. The supplements most often given this label are berberine, soluble fiber (like psyllium or glucomannan), and green tea extract. None work the way GLP-1 receptor agonists do, and none are FDA-approved for weight loss [3].

Common ingredients (berberine, fiber, green tea extract)

Berberine is a plant alkaloid investigated mainly for blood sugar and cholesterol; it is not FDA-approved for weight loss [3]. A 2022 meta-analysis found it was associated with a reduction in body weight of about 2 kg (around 4.4 pounds) on average versus placebo across trials lasting 8–24 weeks [7]. The studies were small and varied in quality, and reported side effects include GI upset, constipation, and potential drug interactions through CYP enzymes [7]. Soluble fiber may promote fullness and slow gastric emptying — useful for satiety, but typical weight loss in trials is only 1–3 pounds beyond diet alone, and high doses can cause bloating or interfere with medication absorption [3]. Green tea extract (often standardized for EGCG and caffeine) has shown small effects on body weight in meta-analyses, generally less than 2–3 pounds, and high-dose extracts have been linked by FDA and case reports to hepatotoxicity [3][8].

What the evidence actually shows

Even the better-studied supplements produce a small fraction of the weight loss seen with prescription GLP-1s. In the STEP 1 trial, semaglutide 2.4mg weekly was associated with an average 14.9% body weight reduction over 68 weeks, paired with GI side effects (nausea, vomiting, diarrhea, constipation) and contraindications for medullary thyroid carcinoma and MEN2 [4]. In SURMOUNT-1, tirzepatide produced about 20.9% average weight loss over 72 weeks with a similar side effect profile [5]. No OTC supplement has matched anything close to those numbers in a randomized trial.

Safety and regulation gaps

Because supplements don't require FDA review as drugs, independent testing has repeatedly found products spiked with unlisted prescription drugs (including sibutramine, which was withdrawn from the U.S. market for cardiovascular risk) [9]. If you choose a supplement, look for third-party testing like USP, NSF, or ConsumerLab, and tell your clinician what you're taking — interactions with prescription medications are common.

OTC vs. prescription weight loss medications: how do they compare?

Here's a side-by-side look at the main options patients ask about. Weight loss figures are averages from published trials; individual results vary. Costs are typical U.S. cash-pay ranges and change frequently.

Who is a candidate for OTC weight loss medication?

BMI and health criteria

Alli's label is intended for adults aged 18 and over with a BMI of 25 or higher, used with a reduced-calorie, low-fat diet [1]. It is not appropriate during pregnancy or breastfeeding, in people who have had organ transplants, in those taking cyclosporine, or in anyone with chronic malabsorption or cholestasis [1]. If you take a blood thinner like warfarin or medication for diabetes or seizures, talk to a clinician or pharmacist first — orlistat can affect how those medications work [1].

When to talk to a clinician instead

If your BMI is 30 or higher, or 27 or higher with a weight-related condition like type 2 diabetes, high blood pressure, or sleep apnea, you may qualify for prescription weight loss medications that produce substantially larger average weight loss in trials, though with their own side effects and contraindications [4][5][6]. A clinician can also screen for underlying causes of weight gain (thyroid disease, PCOS, certain medications) that OTC products won't address.

What are the prescription alternatives if OTC isn't enough?

GLP-1 receptor agonists: semaglutide and compounded semaglutide

Semaglutide is a GLP-1 receptor agonist sold as Wegovy (FDA-approved for chronic weight management) and Ozempic (FDA-approved for type 2 diabetes) [4]. It mimics a gut hormone that signals fullness and slows stomach emptying. In the STEP 1 trial, weekly semaglutide was associated with an average 14.9% weight loss over 68 weeks [4]. Common side effects are GI — nausea, constipation, diarrhea, occasional vomiting — and it is contraindicated in pregnancy and in people with a personal or family history of medullary thyroid carcinoma or MEN2; the label also carries warnings for pancreatitis, gallbladder disease, and acute kidney injury [4]. Compounded semaglutide is a non-FDA-approved formulation prepared by licensed 503A pharmacies under an individual prescription; the FDA has stated compounded products do not undergo the same review for safety, effectiveness, or quality as approved drugs [10]. We cover this in more depth in our compounded semaglutide guide.

GLP-1/GIP: tirzepatide and compounded tirzepatide

Tirzepatide activates both GLP-1 and GIP receptors and is sold as Zepbound (FDA-approved for chronic weight management) and Mounjaro (FDA-approved for type 2 diabetes) [5]. In SURMOUNT-1, weekly tirzepatide was associated with an average 20.9% weight loss over 72 weeks — the largest figure for any FDA-approved weight loss drug to date [5]. Side effects mirror semaglutide (nausea, diarrhea, vomiting, constipation) and the same thyroid-related contraindications and pancreatitis/gallbladder warnings apply [5]. Compounded tirzepatide is similarly a non-FDA-approved formulation available through 503A pharmacies [10]. For a side-by-side, see our Wegovy vs Zepbound comparison and compounded tirzepatide guide.

Oral options: orforglipron, phentermine, bupropion-naltrexone

Newer and older oral prescription options exist too. Orforglipron (Foundayo) is an oral, non-peptide GLP-1 receptor agonist that does not require injection; published phase 3 data report nausea, diarrhea, and vomiting as the most common side effects [11]. Phentermine-topiramate (Qsymia) and bupropion-naltrexone (Contrave) are older FDA-approved oral combinations with more modest average weight loss (around 7–9%) and their own contraindications — including uncontrolled hypertension, cardiovascular disease, glaucoma, pregnancy, seizure disorders, and certain mood considerations [6]. Liraglutide (Saxenda) is a daily-injection GLP-1 with a similar GI side-effect profile and thyroid contraindications [6]. None of these are sold over the counter.

How can I access prescription weight loss medication?

Telehealth evaluation and eligibility

Most prescription weight loss medications can be evaluated and prescribed through telehealth. A clinician will review your medical history, current medications, BMI, and weight-related conditions to determine whether you may be a candidate. Chia is one of several licensed telehealth providers offering this evaluation — patients can complete a clinical intake online and, if appropriate, be prescribed brand-name or compounded GLP-1 options through a partnered pharmacy. If you'd like to learn more, our guide to getting GLP-1 medication online walks through the process.

Cost and insurance considerations

Brand-name Wegovy and Zepbound list around $1,000–$1,350 per month without insurance, though manufacturer savings programs can lower this for some eligible patients [4][5]. Insurance coverage for weight loss medications remains inconsistent — many commercial plans still exclude them, and Medicare generally covers GLP-1s only for FDA-approved indications like type 2 diabetes or cardiovascular risk reduction [6].

Compounded GLP-1s through licensed 503A pharmacies

Compounded semaglutide and tirzepatide are prepared by licensed 503A compounding pharmacies for individual patients under a prescription. They are not FDA-approved products — the FDA has noted that compounded versions do not undergo the same review for safety, effectiveness, or quality as approved drugs [10]. They became more widely available during FDA-declared shortages of brand-name versions, and access continues to evolve as those shortages resolve [10]. The same contraindications and side effects associated with the active ingredient still apply [4][5]. For a deeper comparison, see berberine vs semaglutide.

Frequently asked questions

Keep reading

GLP-1 Weight Loss

How to Get Weight Loss Injections: A Step-by-Step Guide

GLP-1 & Weight Loss

Microdosing GLP-1s: What It Means, Who It's For, and What the Evidence Says

GLP-1 Weight Loss

Microdosing Tirzepatide: What It Means and How It Works